LONDON, UK – Prinova Europe has agreed an exclusive deal to distribute Hofseth BioCare’s marine nutrition products in Europe.

Based in Norway, Hofseth BioCare (HBC) offers a wide range of protein, calcium and oil products from Norwegian salmon. HBC uses proprietary hydrolysis technology to extract nutrients from the fish sustainably, turning offcuts into high-value nutrition products with minimal waste. Products in HBC’s range include:

ProGo® Salmon Protein Hydrolysate
A soluble protein powder for sports, endurance and recovery nutrition. Containing more than 97% pure hydrolysed protein, ProGo is clinically proven to reduce BMI and body fat. Ideal for powder formulations, bars, drinks and tablets, it has also been shown to address iron deficiency anaemia.

CollaGo® Collagen Peptides
A soluble Type I & III Collagen Peptide powder optimised for beauty (hair, skin and nails). Also offering benefits for muscular and vascular health and energy, it can be used in formats including powders, bars, tablets and beverages.

CalGo® Marine Bone Powder
A collagen calcium powder containing 24 % Type II Collagen, 19 % elemental Calcium and 9 % elemental Phosphorous. Designed to support cartilage function and heart health, it can be used in tablets, powders and other formats.

OmeGo® Salmon Oil
A full spectrum of omega fatty acids, including Omega 3, 5, 6, 7, 9 & 11, EPA, DHA and DPA. Offering benefits for the maintenance of healthy cholesterol and cardiovascular function, it can be used in soft gel caps and other formats.

Tony Gay, Head of Technical Sales & NPD at Prinova Europe, said: “We’re very excited to have the opportunity to represent Hofseth BioCare in the European market. They’re a pioneer in the marine ingredients market, combining high quality with a commitment to innovation, sustainability and traceability. At a time of increasing interest in ethically produced marine ingredients, their range is perfectly in line with consumer trends.”

In HBC’s proprietary process, enzymes hydrolyse protein from the fish into peptides, leaving the oil and bones untouched. The peptides are then separated off into unprocessed natural fish oil (OmeGo®) and natural marine collagen and calcium (CalGo®).

Roger Hofseth, CEO of Hofseth BioCare, said: “Our unique technology makes it possible for us to create products using the whole fish, with zero waste. All our processes are focused on sustainability. We also offer total traceability – we can track our production process all the way from fish eggs to final products. There are many applications for our products in nutrition markets, and we’re delighted to be partnering with Prinova.”

Hofseth BioCare’s commitment to sustainability and zero waste has been recognised with Friend of the Sea Certification. Its entire product range is also non-GMO and free from antibiotics, solvents and chemicals.

Prinova Europe is already working on concepts to showcase the benefits of HBC’s products for Beauty from Within, Exercise Recovery & Energy, Cardiovascular Support and Bone Health.

HBC also offers easily absorbed bioactive peptides derived from proprietary enzymatic technology. It is developing these into healthcare products for the treatment of iron-deficiency anaemia, Irritable Bowel Syndrome and sarcopenia.

About Prinova Europe

Since 1978, Prinova has been a leader in providing high-quality ingredients, flavours and value-added nutrient fortification products to the global food, feed and wellness industries. Prinova operates six plants and holds strategic stocks in more than 35 distribution centres around the world to ensure continuity of supply and is the leading global supplier of Vitamin C, B and food grade Amino Acids. The company also has a team of application and technical specialists within their R&D and Quality Laboratory to help customers develop, improve, and enhance the taste and function of their products. Prinova’s facilities are BRC certified. The company’s main corporate office is in Carol Stream, Illinois with the European head office in the United Kingdom and a regional office in Canada. Additional regional offices are located throughout the United States as well as global sales associates in Mexico, Spain, Germany, Belgium, France, Australia, Turkey and China.

For more information, visit Company’s website.

About Hofseth BioCare

Hofseth BioCare  is a Norwegian biotech company that develops high-value ingredients and finished products. Ingredients are further developed into discovery and pre-clinical studies in multiple clinics and university research labs in several countries. Lead clinical and pre-clinical candidates are development towards a Gastro-Intestinal (GI) Protective Medical Food, Medical Food to help treat age-related Sarcopenia, and future phase 1 studies on treatment of Anemia and NEC-IBS with Salmon Protein Hydrolysate fractions.

The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through an innovative hydrolysis technology, HBC can preserve the quality of lipids, proteins and calcium from fresh salmon off-cuts. Hofseth BioCare’s headquarters are in Ålesund, Norway with branches in Oslo, Chicago, Mumbai, Palo Alto and Tokyo.

For more information, visit Company’s website.